Nippon Shinyaku Co Ltd 4516
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3,966.00
- Day Range
- ¥3,947.00–4,005.00
- 52-Week Range
- ¥2,694.00–6,241.00
- Bid/Ask
- ¥3,994.00 / ¥4,002.00
- Market Cap
- ¥269.41 Bil
- Volume/Avg
- 428,700 / 388,395
Key Statistics
- Price/Earnings (Normalized)
- 10.51
- Price/Sales
- 1.79
- Dividend Yield (Trailing)
- 3.10%
- Dividend Yield (Forward)
- 3.10%
- Total Yield
- 3.10%
Company Profile
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 2,213
- Website
- http://www.nippon-shinyaku.co.jp
Comparables
Valuation
|
Metric
|
4516
|
4554
|
2929
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.51 | 11.58 | 6.57 |
Price/Book Value | 1.22 | 0.74 | 2.48 |
Price/Sales | 1.79 | 0.73 | 0.40 |
Price/Cash Flow | 9.92 | 4.54 | 4.34 |
Price/Earnings
4516
4554
2929
Financial Strength
|
Metric
|
4516
|
4554
|
2929
|
|---|---|---|---|
Quick Ratio | 3.11 | 0.55 | 0.81 |
Current Ratio | 4.40 | 1.24 | 1.11 |
Interest Coverage | 101.20 | 58.74 | 95.38 |
Quick Ratio
4516
4554
2929
Profitability
|
Metric
|
4516
|
4554
|
2929
|
|---|---|---|---|
Return on Assets (Normalized) | 10.26% | 4.98% | 14.13% |
Return on Equity (Normalized) | 12.13% | 10.16% | 56.21% |
Return on Invested Capital (Normalized) | 11.86% | 6.17% | 17.85% |
Return on Assets
4516
4554
2929
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hdhqbpqhk | Xpwy | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Kshbpmbbq | Ktcfghr | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Krknlfg | Wxjnp | $45.9 Bil | |||
| Viatris Inc
VTRS
| Qzfyywbc | Dkt | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qgjwkjz | Pnmhc | $13.2 Bil | |||
| Catalent Inc
CTLT
| Jqdtxrkw | Xrndq | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Vkwhgvg | Xzvpmm | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Lfcxrkgd | Wcqys | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Xgvvsvblq | Wgp | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Dsfhqnn | Sstdb | $2.2 Bil |
United States